NCT01713582 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 4
- group Id
- BG005
- value
- 8
- group Id
- BG006
- value
- 7
- group Id
- BG007
- value
- 6
- group Id
- BG008
- value
- 6
- group Id
- BG009
- value
- 18
- group Id
- BG010
- value
- 16
- group Id
- BG011
- value
- 5
- units
- Participants
- groups
- description
- Participants received 10 mg MK-8628/OTX015 administered orally (PO), once daily (QD), in a fasted state on Days 1 to 14 of a 21-day cycle.
- id
- BG000
- title
- AL 10 mg QD 14-21
- description
- Participants received 20 mg MK-8628/OTX015 administered PO, QD, in a fasted state on Days 1 to 14 of a 21-day cycle.
- id
- BG001
- title
- AL 20 mg QD 14-21
- description
- Participants received 40 mg MK-8628/OTX015 administered PO, QD, in a fasted state on Days 1 to 14 of a 21-day cycle.
- id
- BG002
- title
- AL 40 mg QD 14-21
- description
- Participants received 20 mg MK-8628/OTX015 administered PO, twice a day (BID), with the first daily dose in a fasted state, on Days 1 to 21 of a 21-day cycle.
- id
- BG003
- title
- AL 20 mg BID 21-21
- description
- Participants received 80 mg MK-8628/OTX015 administered PO, QD, in a fasted state on Days 1 to 14 of a 21-day cycle.
- id
- BG004
- title
- AL 80 mg QD 14-21
- description
- Participants received 40 mg MK-8628/OTX015 administered PO, twice a day (BID), with the first daily dose in a fasted state, on Days 1 to 14 of a 21-day cycle.
- id
- BG005
- title
- AL 40 mg BID 14-21
- description
- Participants received 120 mg MK-8628/OTX015 administered PO, QD, in a fasted state on Days 1 to 14 of a 21-day cycle.
- id
- BG006
- title
- AL 120 mg QD 14-21
- description
- Participants received 120 mg MK-8628/OTX015 administered PO, QD, in a fasted state on Days 1 to 21 of a 21-day cycle.
- id
- BG007
- title
- AL 120 mg QD 21-21
- description
- Participants received 160 mg MK-8628/OTX015 administered PO, QD, in a fasted state on Days 1 to 14 of a 21-day cycle.
- id
- BG008
- title
- AL 160 mg QD 14-21
- description
- Participants received 80 mg MK-8628/OTX015 administered PO, QD, in a fasted state on Days 1 to 14 of a 21-day cycle.
- id
- BG009
- title
- AML de Novo 80 mg QD 14-21
- description
- Participants received 80 mg MK-8628/OTX015 administered PO, QD, in a fasted state on Days 1 to 14 of a 21-day cycle.
- id
- BG010
- title
- AML/MDS 80 mg QD 14-21
- description
- Participants received 10 mg MK-8628/OTX015 administered PO, QD, in a fasted state on Days 1 to 21 of a 21-day cycle.
- id
- BG011
- title
- OHM 10 mg QD 21-21
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 65.0
- spread
- 3.5
- upper Limit
- 71.0
- value
- 67.0
- group Id
- BG001
- lower Limit
- 32.0
- spread
- 19.6
- upper Limit
- 66.0
- value
- 54.7
- group Id
- BG002
- lower Limit
- 71.0
- spread
- 2.1
- upper Limit
- 76.0
- value
- 73.8
- group Id
- BG003
- lower Limit
- 75.0
- spread
- 2.3
- upper Limit
- 79.0
- value
- 77.7
- group Id
- BG004
- lower Limit
- 55.0
- spread
- 10.6
- upper Limit
- 80.0
- value
- 70.0
- group Id
- BG005
- lower Limit
- 33.0
- spread
- 16.3
- upper Limit
- 85.0
- value
- 65.8
- group Id
- BG006
- lower Limit
- 42.0
- spread
- 13.9
- upper Limit
- 79.0
- value
- 65.3
- group Id
- BG007
- lower Limit
- 19.0
- spread
- 24.1
- upper Limit
- 80.0
- value
- 58.5
- group Id
- BG008
- lower Limit
- 26.0
- spread
- 16.6
- upper Limit
- 75.0
- value
- 57.8
- group Id
- BG009
- lower Limit
- 45.0
- spread
- 10.0
- upper Limit
- 79.0
- value
- 65.6
- group Id
- BG010
- lower Limit
- 48.0
- spread
- 8.2
- upper Limit
- 81.0
- value
- 67.2
- group Id
- BG011
- spread
- 15.5
- value
- 65.2
- denoms
- counts
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 4
- group Id
- BG005
- value
- 8
- group Id
- BG006
- value
- 7
- group Id
- BG007
- value
- 6
- group Id
- BG008
- value
- 6
- group Id
- BG009
- value
- 18
- group Id
- BG010
- value
- 16
- group Id
- BG011
- value
- 5
- units
- Participants
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 3
- group Id
- BG006
- value
- 3
- group Id
- BG007
- value
- 2
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 8
- group Id
- BG010
- value
- 3
- group Id
- BG011
- value
- 0
- title
- Female
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 4
- group Id
- BG005
- value
- 5
- group Id
- BG006
- value
- 4
- group Id
- BG007
- value
- 4
- group Id
- BG008
- value
- 6
- group Id
- BG009
- value
- 10
- group Id
- BG010
- value
- 13
- group Id
- BG011
- value
- 5
- title
- Male
- denoms
- counts
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 4
- group Id
- BG005
- value
- 8
- group Id
- BG006
- value
- 7
- group Id
- BG007
- value
- 6
- group Id
- BG008
- value
- 6
- group Id
- BG009
- value
- 18
- group Id
- BG010
- value
- 16
- group Id
- BG011
- value
- 5
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG021
- value
- 0
- denoms
- counts
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 0
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- population Description
- Race and Ethnicity were not collected from any participant.
- title
- Race and Ethnicity Not Collected
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 4
- group Id
- BG005
- value
- 8
- group Id
- BG006
- value
- 7
- group Id
- BG007
- value
- 6
- group Id
- BG008
- value
- 6
- group Id
- BG009
- value
- 18
- group Id
- BG010
- value
- 16
- group Id
- BG011
- value
- 5
- units
- Participants
- groups
- description
- Participants received 10 mg MK-8628/OTX015 administered orally (PO), once daily (QD), in a fasted state on Days 1 to 14 of a 21-day cycle.
- id
- BG000
- title
- AL 10 mg QD 14-21
- description
- Participants received 20 mg MK-8628/OTX015 administered PO, QD, in a fasted state on Days 1 to 14 of a 21-day cycle.
- id
- BG001
- title
- AL 20 mg QD 14-21
- description
- Participants received 40 mg MK-8628/OTX015 administered PO, QD, in a fasted state on Days 1 to 14 of a 21-day cycle.
- id
- BG002
- title
- AL 40 mg QD 14-21
- description
- Participants received 20 mg MK-8628/OTX015 administered PO, twice a day (BID), with the first daily dose in a fasted state, on Days 1 to 21 of a 21-day cycle.
- id
- BG003
- title
- AL 20 mg BID 21-21
- description
- Participants received 80 mg MK-8628/OTX015 administered PO, QD, in a fasted state on Days 1 to 14 of a 21-day cycle.
- id
- BG004
- title
- AL 80 mg QD 14-21
- description
- Participants received 40 mg MK-8628/OTX015 administered PO, twice a day (BID), with the first daily dose in a fasted state, on Days 1 to 14 of a 21-day cycle.
- id
- BG005
- title
- AL 40 mg BID 14-21
- description
- Participants received 120 mg MK-8628/OTX015 administered PO, QD, in a fasted state on Days 1 to 14 of a 21-day cycle.
- id
- BG006
- title
- AL 120 mg QD 14-21
- description
- Participants received 120 mg MK-8628/OTX015 administered PO, QD, in a fasted state on Days 1 to 21 of a 21-day cycle.
- id
- BG007
- title
- AL 120 mg QD 21-21
- description
- Participants received 160 mg MK-8628/OTX015 administered PO, QD, in a fasted state on Days 1 to 14 of a 21-day cycle.
- id
- BG008
- title
- AL 160 mg QD 14-21
- description
- Participants received 80 mg MK-8628/OTX015 administered PO, QD, in a fasted state on Days 1 to 14 of a 21-day cycle.
- id
- BG009
- title
- AML de Novo 80 mg QD 14-21
- description
- Participants received 80 mg MK-8628/OTX015 administered PO, QD, in a fasted state on Days 1 to 14 of a 21-day cycle.
- id
- BG010
- title
- AML/MDS 80 mg QD 14-21
- description
- Participants received 10 mg MK-8628/OTX015 administered PO, QD, in a fasted state on Days 1 to 21 of a 21-day cycle.
- id
- BG011
- title
- OHM 10 mg QD 21-21
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 65.0
- spread
- 3.5
- upper Limit
- 71.0
- value
- 67.0
- group Id
- BG001
- lower Limit
- 32.0
- spread
- 19.6
- upper Limit
- 66.0
- value
- 54.7
- group Id
- BG002
- lower Limit
- 71.0
- spread
- 2.1
- upper Limit
- 76.0
- value
- 73.8
- group Id
- BG003
- lower Limit
- 75.0
- spread
- 2.3
- upper Limit
- 79.0
- value
- 77.7
- group Id
- BG004
- lower Limit
- 55.0
- spread
- 10.6
- upper Limit
- 80.0
- value
- 70.0
- group Id
- BG005
- lower Limit
- 33.0
- spread
- 16.3
- upper Limit
- 85.0
- value
- 65.8
- group Id
- BG006
- lower Limit
- 42.0
- spread
- 13.9
- upper Limit
- 79.0
- value
- 65.3
- group Id
- BG007
- lower Limit
- 19.0
- spread
- 24.1
- upper Limit
- 80.0
- value
- 58.5
- group Id
- BG008
- lower Limit
- 26.0
- spread
- 16.6
- upper Limit
- 75.0
- value
- 57.8
- group Id
- BG009
- lower Limit
- 45.0
- spread
- 10.0
- upper Limit
- 79.0
- value
- 65.6
- group Id
- BG010
- lower Limit
- 48.0
- spread
- 8.2
- upper Limit
- 81.0
- value
- 67.2
- group Id
- BG011
- spread
- 15.5
- value
- 65.2
- denoms
- counts
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 4
- group Id
- BG005
- value
- 8
- group Id
- BG006
- value
- 7
- group Id
- BG007
- value
- 6
- group Id
- BG008
- value
- 6
- group Id
- BG009
- value
- 18
- group Id
- BG010
- value
- 16
- group Id
- BG011
- value
- 5
- units
- Participants
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 3
- group Id
- BG006
- value
- 3
- group Id
- BG007
- value
- 2
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 8
- group Id
- BG010
- value
- 3
- group Id
- BG011
- value
- 0
- title
- Female
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 4
- group Id
- BG005
- value
- 5
- group Id
- BG006
- value
- 4
- group Id
- BG007
- value
- 4
- group Id
- BG008
- value
- 6
- group Id
- BG009
- value
- 10
- group Id
- BG010
- value
- 13
- group Id
- BG011
- value
- 5
- title
- Male
- denoms
- counts
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 4
- group Id
- BG005
- value
- 8
- group Id
- BG006
- value
- 7
- group Id
- BG007
- value
- 6
- group Id
- BG008
- value
- 6
- group Id
- BG009
- value
- 18
- group Id
- BG010
- value
- 16
- group Id
- BG011
- value
- 5
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG021
- value
- 0
- denoms
- counts
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 0
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- population Description
- Race and Ethnicity were not collected from any participant.
- title
- Race and Ethnicity Not Collected
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle